印度制药业对美国通用名药物市场的影响.pdf

No. 2007-05-A OFFICE OF ECONOMICS WORKING PAPER U.S. INTERNATIONAL TRADE COMMISSION The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market William Greene U.S. International Trade Commission May 2007 The author is with the Office of Economics of the U.S. International Trade Commission. Office of Economics working papers are the result of the ongoing professional research of USITC Staff and are solely meant to represent the opinions and professional research of individual authors. These papers are not meant to represent in any way the views of the U.S. International Trade Commission or any of its individual Commissioners. Working papers are circulated to promote the active exchange of ideas between USITC Staff and recognized experts outside the USITC, and to promote professional development of Office staff by encouraging outside professional critique of staff research. Address correspondence to: Office of Economics U.S. International Trade Commission Washington, DC 20436 USA The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market William Greene U.S. International Trade Commission ABSTRACT: This paper presents an overview of India’s pharmaceutical industry and its evolution from almost non-existent to one o